Advocacy Alert: Push for Community-Based Psychedelic Access Challenges Clinical Model

This article advocates for a paradigm shift in psychedelic access, moving beyond the current focus on clinical models towards community-based frameworks. It argues that while scientific validation is crucial, exclusive clinical pathways limit accessibility and fail to address how most people already use psychedelics. Merchants should monitor this evolving advocacy landscape, as successful community integration could necessitate different regulatory and compliance strategies for broader public access beyond medical settings.